CUTANEOUS NOCARDIOSIS

CUTANEOUS NOCARDIOSIS was reported 130 times

These drug classes are most commonly taken by patients reporting CUTANEOUS NOCARDIOSIS:

# Drug Count
0 Corticosteroid [EPC] 106
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 19
2 Purine Antimetabolite [EPC] 13
3 Tumor Necrosis Factor Blocker [EPC] 13
4 Antimetabolite Immunosuppressant [EPC] 12
5 Antimalarial [EPC] 9
6 Antiprotozoal [EPC] 9
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 9
8 Azole Antifungal [EPC] 7
9 Thalidomide Analog [EPC] 7
10 Oxazolidinone Antibacterial [EPC] 6
11 Sulfone [EPC] 5
12 CD20-directed Cytolytic Antibody [EPC] 4
13 Calcineurin Inhibitor Immunosuppressant [EPC] 4
14 Folate Analog Metabolic Inhibitor [EPC] 4
15 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4
16 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4
17 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4
18 Interleukin-2 Receptor Blocking Antibody [EPC] 4
19 Kinase Inhibitor [EPC] 4
20 Phosphodiesterase 4 Inhibitor [EPC] 4
21 Proteasome Inhibitor [EPC] 4
22 mTOR Inhibitor Immunosuppressant [EPC] 4
23 Aldosterone Antagonist [EPC] 3
24 Dietary Cholesterol Absorption Inhibitor [EPC] 3
25 Immunoglobulin G [EPC] 3
26 Loop Diuretic [EPC] 3
27 Penem Antibacterial [EPC] 3
28 Vitamin B12 [EPC] 3
29 Vitamin C [EPC] 3
30 Vitamin D [EPC] 3
31 Xanthine Oxidase Inhibitor [EPC] 3
32 alpha-Adrenergic Blocker [EPC] 3
33 beta-Adrenergic Blocker [EPC] 3
34 Alkylating Drug [EPC] 2
35 Complement Inhibitor [EPC] 2
36 Fluoroquinolone Antibacterial [EPC] 2
37 Selective T Cell Costimulation Blocker [EPC] 2
38 Tetracycline-class Drug [EPC] 2
39 Antimycobacterial [EPC] 1
40 Antirheumatic Agent [EPC] 1
41 CD52-directed Cytolytic Antibody [EPC] 1
42 CTLA-4-directed Blocking Antibody [EPC] 1
43 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
44 Erythropoiesis-stimulating Agent [EPC] 1
45 Factor Xa Inhibitor [EPC] 1
46 Glycopeptide Antibacterial [EPC] 1
47 HMG-CoA Reductase Inhibitor [EPC] 1
48 Histamine-2 Receptor Antagonist [EPC] 1
49 Human Immunoglobulin G [EPC] 1
50 Interleukin-5 Antagonist [EPC] 1
51 Interleukin-6 Receptor Antagonist [EPC] 1
52 Leukocyte Growth Factor [EPC] 1
53 Lipid-based Polyene Antifungal [EPC] 1
54 Microtubule Inhibitor [EPC] 1
55 Nonsteroidal Anti-inflammatory Drug [EPC] 1
56 Nucleoside Metabolic Inhibitor [EPC] 1
57 Parathyroid Hormone Analog [EPC] 1
58 Polyene Antifungal [EPC] 1
59 Sulfonamide Antimicrobial [EPC] 1